|
| |
| | | | 1 | | | DO1.PCCNTR.2028315 ContractData Container |
| | | 1.1 | | | | | | | | | | 398,634,800.00 | 0.00 | 0.00 | 0.00 | 380,618,000.00 | 398,634,800.00 |
|
| | | | | | | 7 | | 51131802 - Factores antih(...)51131802 - Factores antihemofílicos o globulinas |
| 2.3.4.1.01 | Factor IX 500 Ui | 700 | UD | 9,500 | 9,550 | 6,685,000.00 | | 0.00 | | | 0.00 | | 0.00 | 6,650,000.00 | 6,685,000.00 | |
|
| | | | | | | 5 | | 2.3.4.1.01 | Dornasa Alfa 2.5 Mg / 2.5 Ml | 8,472 | UD | 2,350 | 2,450 | 20,756,400.00 | | 0.00 | | | 0.00 | | 0.00 | 19,909,200.00 | 20,756,400.00 | |
|
| | | | | | | 8 | | 51131802 - Factores antih(...)51131802 - Factores antihemofílicos o globulinas |
| 2.3.4.1.01 | Factor VIII De Coagulacion Humana 500ui/vial | 7,000 | UD | 5,750 | 6,700 | 46,900,000.00 | | 0.00 | | | 0.00 | | 0.00 | 40,250,000.00 | 46,900,000.00 | |
|
| | | | | | | 16 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | Tocilizumab 200mg/10Ml | 4,698 | UD | 17,700 | 18,300 | 85,973,400.00 | | 0.00 | | | 0.00 | | 0.00 | 83,154,600.00 | 85,973,400.00 | |
|
| | | | | | | 11 | | 2.3.4.1.01 | Pertuzumab 420 Mg / 14 Ml | 499 | UD | 201,000 | 208,000 | 103,792,000.00 | | 0.00 | | | 0.00 | | 0.00 | 100,299,000.00 | 103,792,000.00 | |
|
| | | | | | | 13 | | 2.3.4.1.01 | Rituximab 500 Mg /50 Ml Innovador | 2,560 | UD | 50,920 | 52,550 | 134,528,000.00 | | 0.00 | | | 0.00 | | 0.00 | 130,355,200.00 | 134,528,000.00 | |
|
|
| | | |
| | | |
|